Meningitis Vaccine Dangers

🖨️ Print post

The Terrain Of Truth: Rethinking Meningitis And The Roots Of Health

Few diagnoses strike fear into the hearts of parents like meningitis. Stories of sudden fever, rapid decline and devastating consequences circulate like folklore, reinforced by headlines and public health campaigns. Although U.S. rates of meningitis have fallen precipitously since the 1990s,¹ health officials continue to echo this urgency, presenting vaccines as the surest line of meningitis defense—an unquestionable safeguard against catastrophe.

Fear, while a potent motivator, often nar­rows the lens through which we see. What gets lost when this type of anxiety becomes the frame? And what truths emerge when we begin to look more closely—not just at the disease, but at the terrain in which it takes hold? It’s important to explore the medical framework that officials use to define meningitis, for this foundation shapes the public’s perceptions and responses.

THE OFFICIAL STORY

Meningitis (also called spinal meningitis) refers to inflammation of the membranes that cover and protect the brain and spinal cord, known as the meninges. These membranes play a vital role in shielding the central nervous system, offering structural support and housing nerves, blood vessels and cerebrospinal fluid.²

According to the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), meningitis can be acute (defined by sudden onset and severity) or chronic (symptoms lasting a month or more) and either infectious—caused by bacteria, viruses, fungi or parasites—or non-infectious, triggered by factors such as head injuries or cancer.^2-4 Interestingly, medicine also acknowledges one form of iatro­genic meningitis, called drug-induced aseptic meningitis (DIAM), linked to medications like nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics.⁵ The perceived cause and the duration of a person’s symptoms determine how a meningitis case gets classified.

Public health organizations state that the most common form is “vi­ral” meningitis. In addition to enteroviruses, we are told that a wide range of other viruses can cause meningitis, including herpes simplex (types 1 and 2), varicella-zoster (chickenpox), Epstein-Barr, mumps, measles, influenza, HIV and West Nile.⁶ Bacterial meningitis is described as far less common but significantly more dangerous, requiring urgent medical care due to its rapid progression and potential for severe complications and even death.

The most common symptoms attributed to meningitis include sudden fever, headache and a stiff neck. Other frequently reported symptoms are nausea, vomiting, increased sensitivity to light (photophobia) and confu­sion or difficulty concentrating. As the illness progresses, individuals may experience seizures, sleepiness (or difficulty waking) and, in severe cases, coma. In babies, instead of these “classic” symptoms, meningitis is said to manifest as unusual fussiness, sleepi­ness and a bulging soft spot (fontanelle) on the head; infants may also be hard to comfort and may feed poorly.⁴

Public health officials assert that both bacte­rial and viral meningitis are contagious—that is, spread through various forms of close personal contact (bacterial) or via coughing, sneezing or touch (viral).^7,8 As with other diseases of recent memory, they also warn that a person can transmit the bacterium or virus in question while being asymptomatic themselves.⁹ Follow­ing this all-too-familiar logic, warnings about meningitis go hand in hand with promotion of certain vaccines,⁷ particularly for populations deemed to be more at risk, such as infants, young children and college students.¹⁰ First-year students living in campus housing are a particular target for vaccination because shared or crowded living conditions are said to facilitate bacterial and viral transmission.

In reality, the CDC’s own surveillance data indicate that the risk of meningitis in adolescents and young adults is exceedingly low. In 2023, the Enhanced Meningococcal Disease Surveil­lance (EMDS) system received reports of four hundred thirty-seven “confirmed and prob­able” meningitis cases across all age groups, only thirty-eight (8.7 percent) of which were in sixteen- to twenty-three-year-olds.¹¹ More than half of all “confirmed and probable” cases (54 percent) were in adults aged forty-five or older. (See sidebar below for a look at the doubtful methods used to count a case as “confirmed” or “probable.”)

REVISITING GERM THEORY (AGAIN)

One of the most persistent and least ques­tioned assumptions about meningitis is the germ-theory-derived belief that most types of meningitis are contagious. Germ theory, popularized by Louis Pasteur in the nineteenth century, posits that bacteria and viruses invade the body and cause disease. These are the ideas that gave rise to the pharmaceutical model we live with today: one disease, one microbe, one drug or vaccine.

As Daniel Roytas explains in Can You Catch a Cold? Untold History & Human Experiments, in a chapter titled “Béchamp versus Pasteur,” Pasteur’s contemporary, Antoine Béchamp, proposed a radically different theory.¹² Béchamp held that disease originates from within the body and that microbes represent a symptom of illness, not the cause. He believed that tiny particles in the blood, which he called “microzymas,” were the fundamental building blocks of life and could transform into various microbial forms depending on the condition of the body’s internal terrain. According to this concept, known as pleomorphism, bacteria and other microbes do not exist in fixed forms but adapt based on what is going on in their environment. When the body is under stress from toxins, nutri­tional deficiencies, trauma or other insults, microorganisms may change form to metabolize toxins and break down damaged tissue. In this model, bacteria are not enemies to eradicate but an adaptive cleanup crew that supports the body’s efforts to return to equilibrium.

Tom Cowan and Sally Fallon Morell suggest in The Contagion Myth that what we call “infectious disease” is actually a misunderstood and misrepresented detoxification process.¹³ They also point to histori­cal examples of diseases such as scurvy, beriberi and pellagra—once thought to be infectious, later shown to be caused by nutrient deficiencies. Within this framework, “outbreaks” of illness arise not from contagion but from shared exposures, environmental conditions or physiological stress. In Can You Catch a Cold?, Roytas details, in a lengthy appendix, investigators’ repeated failure—in over two hundred experiments—to demonstrate person-to-person transmission of influenza and other dis­eases, even when directly exposing healthy subjects to the blood, mucus, saliva or breath of the sick.

If one accepts that microbes are nature’s cleanup crew, it is evident that our focus should move away from eradication and toward restora­tion—strengthening the body’s natural defenses through lifestyle and environmental changes and supporting the body’s innate capacity to maintain or restore a healthy internal environment. The human body is not static; it is a responsive, self-regulating system that continuously adapts to internal and external stimuli to preserve balance. This dynamic process—homeostasis—allows the body to heal, detoxify and recover. History has taught us the significance of improved sanitation, living con­ditions and nutrition; those are the factors that led to the steep declines documented for major nineteenth- and early twentieth-century killers such cholera, typhoid and scarlet fever.¹⁴

From this perspective, let’s consider some of the real reasons why we might observe illness in college students. Many of today’s students are navigating immense mental, emotional and physical stress. Poor sleep, erratic eating habits, a diet of mostly processed food, alcohol and drug use, high academic and social pressure and disconnection from nature are factors that can compromise students’ terrain and weaken their resilience.

VACCINE PROMOTION: A CORE FEATURE OF THE MENINGITIS NARRATIVE

If microbial expression is a response to internal imbalance rather than the root cause of disease, then the logic of targeting microbes with vaccines—and promoting vaccination as the first and often only line of defense—demands close scrutiny. When it comes to meningitis, public health organizations’ logic is particularly flawed, because although meningitis vaccines target only certain bacterial strains and not putative viral or fungal causes, officials persist in presenting vaccination as the most effective preventive measure.³

Public health agencies hold four types of bacteria responsible for most cases of bacterial meningitis and for at least half of all menin­gitis deaths globally: Neisseria meningitidis (meningococcus), Streptococcus pneumoniae (pneumococcus), Haemophilus influenzae type b (Hib) and Streptococcus agalactiae (group B streptococcus or GBS).³ Existing meningococ­cal conjugate, pneumococcal conjugate and Hib vaccines target the first three, and vaccine manufacturers also have a maternal vaccine within their sights to address risks of mother-to-child transmission of GBS during childbirth.^15,16 In the U.S., there are three types of meningo­coccal vaccines and seven different approved formulations to address different combina­tions of bacterial strains (called “serogroups”): two monovalent MenB vaccines (Bexsero and Trumenba), three quadrivalent MenACWY vac­cines (Menactra, MenQuadfi and Menveo) and, approved in 2023 and 2025, respectively, two pentavalent MenABCWY vaccines (Penbraya and Penmenvy).^17-19

The CDC recommends routine vaccination with multiple doses of PCV and Hib vaccines in the first fifteen months of life, two doses of meningococcal vaccine for preteens and teens at ages eleven to twelve and sixteen,²⁰ one dose of meningococcal vaccine for military recruits and first-year college students living in dorms (if not previously vaccinated at age sixteen or older) and PCV vaccination for adults age fifty years or older (with recommendations varying according to vaccination history).^21,22 There are additional meningococcal recommendations for children and adults with certain medical conditions (including babies as young as two months of age) as well as for children and adults traveling to countries with “hyperendemic or epidemic meningococcal disease.”

The WHO has preferentially recommended mass vaccination with the pentavalent Men5CV vaccine in Africa since 2023, arguing that the vaccine can conquer the so-called “African meningitis belt.”² In lower-risk settings, WHO’s somewhat more selective approach targets trav­elers, immunocompromised individuals and certain occupational groups.

MENINGITIS VACCINE INGREDIENTS AND ADVERSE EVENTS

As Table 1 shows, the disclosed ingredients of meningococcal vaccines approved in the U.S. include problematic substances such as aluminum adjuvants, formaldehyde, polysorbate 80 and sodium chloride.^23,24 All of these come with risks, particularly when injected. The Mayo Clinic warns, for example, that injected sodium chloride can cause serious allergic or infusion reactions, fluid overload and overhydration (leading to fluid in the lungs) and low or high blood sodium levels (associated with a variety of serious problems).²⁵

As for aluminum adjuvants, peer-reviewed studies link aluminum to neurotoxicity, allergic sensitization and autoimmune responses—ef­fects especially troubling for infants and young children with developing brains and immune systems.²⁶ Unlike aluminum that is ingested (most of which is poorly absorbed and rap idly excreted), injected aluminum bypasses the body’s natural filtering mechanisms, entering directly into tissues and circulation where it can accumulate and persist. (For more on aluminum adjuvants, see the article by Dr. Christopher Shaw in this issue of Wise Traditions.)

Vaccine manufacturers list a wide range of adverse reactions to me­ningococcal vaccines in their package inserts, reported in clinical trials or during post-marketing surveillance,^27,28 ranging from milder symptoms like injection-site pain and swelling, fatigue, nausea and fainting to more severe outcomes such as seizures, anaphylaxis, Guillain-Barré syndrome and mystery conditions like Kawasaki disease.²⁹ Internationally, admin­istration of a meningococcal vaccine developed specifically for use in sub-Saharan Africa, called MenAfriVac, left at least forty of five hundred Chadian children paralyzed in 2013.³⁰ In a 2022 paper, an enthusiastic Italian researcher extolled MenAfriVac’s “high immunogenicity” (ability to stir up an immune response), making no mention of adverse events.³¹

In the U.S., adverse events following vaccination are reported through the Vaccine Adverse Event Reporting System (VAERS). Al­though VAERS data do not establish causation, the volume and severity of reports submitted following meningitis-related vaccination raise valid concerns—particularly given that severe meningitis is rare in the U.S. As of July 25, 2025, nearly two hundred sixty-three thousand reports had been filed related to meningitis-associated vaccines (Hib-containing, pneumococcal and meningococcal vaccines combined),³² with almost forty-six thousand classified as serious. These include hospitalizations, permanent disability and deaths, with reported symptoms ranging from myocarditis and seizures to multisystem inflammatory syndromes. Recall, too, that vaccine injuries are vastly underreported; a government-funded study by Harvard Pilgrim Healthcare found that VAERS captures fewer than 1 percent of adverse events.³³

Word about the risks of meningococcal vaccines has trickled out. One law firm openly describes “a host of dangerous meningococcal vaccine side effects” on its website, citing a nearly threefold risk of developing Bell’s palsy or another neurological disorder within twelve weeks of the first dose.³⁴ The attorneys also warn that the “dangers increase significantly when the meningitis vaccine is administered in conjunction with another vaccination,” which is often the case.

SEEING THROUGH THE FEAR

Research published in July 2025 reveals that children in the United States face an 80 percent higher risk of death compared to their peers in other industrialized nations, with nearly half receiving ongoing medical treatment for chronic health issues.³⁵ The study, published in JAMA,³⁶ analyzed hundreds of millions of health records and found that within the U.S., children were 15 to 20 percent more likely to have a chronic condition as of 2023 compared to 2011—including conditions like autism and developmental delays. The study’s first author told CNN, “In the ‘90s, when [I] started taking care of children [I] hardly ever saw one with a chronic condition.” In absurd response, we are now witnessing the widespread normalization of childhood chronic illness, as evidenced by the debut of Mattel’s “Diabetic Barbie,”³⁷ who comes complete with an insulin pump and teaches children that disease is not only normal, but to be expected.

Mainstream news coverage of the JAMA study was careful to remain within the Overton window, steering clear of discussing the changes in the childhood vaccine schedule that have coincided with the deterioration in children’s health. Instead, and around the same time, one of the Washington Post’s most reliable vaccine cheerleaders came out with a new fear-monger­ing article about meningitis titled, “Meningitis B is rare but deadly. Parents who lost children to the disease wonder why no one mentioned a vaccine.”³⁸ Adding symbolic weight to this narrative, a group called Meningitis Awareness promotes World Meningitis Day—held annu­ally on October 5—to reinforce the perception of meningitis as an urgent threat solvable only through vaccination.³⁹

More than just a medical tool, vaccination is marketed as a moral imperative, particularly for populations deemed “high risk.” In July 2025, FDA signaled the continuation of this type of messaging, approving Moderna’s Spikevax for “vulnerable” infants and children.⁴⁰ As with Covid-19, messaging about meningitis and other diseases elevates fear, while dismissing terrain theory and positioning pharmaceutical solutions as both inevitable and unassailable. This is not a science-based model of health, but a compliance-based system shaped by corporate and other more hidden interests. If vaccines were truly safe and effective, there would be no need to coerce.

Until recently, the fear and guilt that are deeply embedded in vaccine messaging—whether about meningitis, measles or other diseases—have been all too effective in promoting compliance and persuading the public that pharmaceutical interventions are the only path to safety. This may be changing; a recent survey found that the percentage of U.S. adults supporting vaccine exemptions—whether for philosophical, religious or medical reasons—roughly doubled between 2019 and 2025.⁴¹ As more people step back, ask hard questions and seek a deeper understanding of what it truly means to be healthy, the germ theory paradigm is cracking. This may be why a panicked American Academy of Pediatrics (AAP) is now lobbying for federal mandates on childhood vaccines, seeking to eliminate all nonmedical exemptions.⁴²

We do not need another booster or another fear-based campaign. We need a new model, one that honors informed consent, supports vitality and recognizes the sacred individuality of each human being. We don’t need to fine-tune a broken system—we need to build something new.

---

SIDEBARS

HOW DOES THE CDC DEFINE MENINGITIS “CASES”?

According to the CDC, a “confirmed” case of meningitis involves either “isolation of Neisseria meningitidis or detec­tion of N. meningitidis by PCR from a normally sterile body site.”^10,43 “Probable” cases are defined as “detection of N. meningitidis antigen by latex agglutination or immunohistochemistry.” As faithful readers of Wise Traditions know, there is ample reason to question the use of these methods for purposes of valid diagnosis.⁴⁴

Interestingly, CDC does not discuss how it monitors “viral” meningitis cases or cases attributed to the other bacterial species that it says are common causes of meningitis. Instead, adopting a catch-all approach, the agency tells health care providers to “maintain a heightened index of suspicion” and “be aware of atypical presentations” of meningitis, stating that patients “may present without typical meningitis symptoms.”¹ Not surprisingly, the CDCʼs other key recommendation is to “ensure up-to-date vaccination.”

ARE THEY TRYING TO HIDE SOMETHING?

Though regulatory agencies project confidence about the U.S. vaccine program, its scientific underpinnings—par­ticularly as regards safety in children—are surprisingly incomplete. Consider the following:

• There has never been a large-scale, government-funded study with a randomized, double-blind, placebo-con­trolled design to compare long-term health outcomes between fully vaccinated and completely unvaccinated children.⁴⁵ However, over one hundred smaller-scale “vax-unvax” studies published in the peer-reviewed literature point to superior health outcomes in children and adults who forego some or all vaccines.⁴⁶
• Most vaccine safety trials use another vaccine or an adjuvanted solution as the comparison, rather than an inert placebo such as saline, limiting their validity.⁴⁷
• Health providers administer vaccines according to complex schedules that result in multiple exposures to various ingredients, yet no study has assessed the combined toxicological impact of the full U.S. childhood vaccination schedule as actually given. Independent research increasingly indicates that vaccines and vaccine ingredients can interact synergistically—raising toxicity in ways that trials of individual ingredients or vaccines are not designed to detect.^48,49
• The widely cited concept of vaccine-induced “immune memory” remains theoretical; it has never been directly observed or measured in a living human system over time.
• Pre-licensure trials routinely exclude the populations most vulnerable to vaccine injury—such as pregnant women and children with cancer, autoimmune disease or diabetes—yet after a vaccine receives approval, officials often recommend that these same high-risk individuals be first in line to receive it.
• Most safety studies monitor participants for only days or weeks—periods too brief to permit detection of long-term effects or delayed adverse events.
• Post-licensure surveillance, meanwhile, is passive and incomplete, capturing only a fraction of incidents.⁵⁰

In any other area of medicine, such scientific gaps would halt widespread use. But with vaccines, the public is ex­pected to let assumptions of safety stand in for rigorous proof.

WHAT ABOUT Hib-CONTAINING VACCINES?

CDC claims that Haemophilus influenzae type b (Hib) was the leading cause of bacterial meningitis prior to the intro­duction of “effective” vaccines. As with many other CDC assertions, this merits a closer look. In the early 1980s (before the vaccineʼs rollout), CDC received reports of roughly twenty thousand Hib cases annually (about forty to fifty per hun­dred thousand), largely in children under five.⁵¹ However, a Swedish study showed that in children exclusively breastfed for at least thirteen weeks, the pre-vaccine risk of serious outcomes from this low-incidence disease was minimal, about one in one hundred forty-three thousand.^52,53

The same cannot be said about current Hib vaccines (ActHIB, Hiberix, PedvaxHIB and combination products like Pentacel and Vaxelis), which contain aluminum and other adjuvants. The aluminum adjuvants are present in amounts (for example, two hundred twenty-five mcg in PedvaxHib) that vastly exceed “safe” daily exposure levels for infants.^54-56 As with other childhood vaccines, package inserts also disclose that no Hib vaccine has been evaluated “for carcinogenic or mutagenic potential, or potential to impair fertility.”

Reported Hib vaccine side effects range from fever, vomiting, ear infections, rash and upper respiratory infections to seizures (conservatively estimated at 1 in 1,098 children), type-1 diabetes (1 in 1,852 after four doses), neurological disorders and so-called “sudden infant death syndrome.”⁵⁷ As of July 25, 2025, VAERS had received almost ninety-eight thousand reports of adverse events following Hib vaccination, including over twenty-nine hundred deaths.⁵⁴ The former Institute of Medicine (now called the National Academy of Medicine) admitted in 1994 that available evidence can neither prove nor disprove links between Hib vaccination and several severe outcomes,⁵⁸ and there is no research to confirm CDCʼs claim that Hib vaccines cause less permanent disability and death than Hib itself.⁵² On the contrary, studies show that combination vaccines that include a Hib component are associated with an alarming increase in the risk of infant death.^59,60 However, it is impossible to know whether Hib, another vaccine component or the interaction of various ingredients is responsible.⁶¹

---

REFERENCES

1. Meningococcal disease surveillance and trends. CDC, May 9, 2025.
2. Meningitis. Cleveland Clinic, last reviewed Aug. 22, 2022.
3. Meningitis. WHO, Apr. 1, 2025. www.who.int/news-room/fact-sheets/detail/meningitis
4. About meningitis. CDC, Feb. 12, 2024.
5. Jha P, Stromich J, Cohen M, et al. A rare complication of trimethoprim-sulfamethoxazole: drug induced aseptic meningitis. Case Rep Infect Dis. 2016;2016:3879406.
6. About viral meningitis. CDC, Jan. 9, 2024.
7. About meningococcal disease. CDC, Feb. 1, 2024.
8. About bacterial meningitis. CDC, Jan. 9, 2024.
9. Clinical overview of meningococcal disease. CDC, Feb. 1, 2024.
10. Risk factors for meningococcal disease. CDC, Feb. 1, 2024.
    11. 2023 EMDS Surveillance Report. CDC, Mar. 21, 2025. https://www.cdc.gov/meningococcal/media/pdfs/2025/04/NCIRD-EMDS-Report-2023_508.pdf
11. Roytas D. Can You Catch a Cold? Untold History & Human Experiments. Orlando, FL: Humanley, 2024.
12. Cowan TS, Morell SF, The Contagion Myth: Why Viruses (Including Coronavirus) Are Not the Cause of Disease. Chelsea Green Publishing, 2020.
13. Humphries S, Bystrianyk R. Dissolving Illusions: Dis­ease, Vaccines, and the Forgotten History. CreateSpace Independent Publishing Platform, 2013.
14. About Group B Strep disease. CDC, May 1, 2025.
15. Pfizer announces New England Journal of Medicine publication on Group B Streptococcus (GBS) maternal vaccine candidate. Pfizer, Jul. 19, 2023.
16. Types of meningococcal vaccines. CDC, Jul. 1, 2025.
17. FDA approves PENBRAYA™, the first and only vaccine for the prevention of the five most common serogroups causing meningococcal disease in adolescents. Pfizer, Oct. 20, 2023.
18. Penmenvy, GSK’s 5-in-1 meningococcal vaccine, ap­proved by US FDA to help protect against MenABCWY. GSK, Feb. 15, 2025.
19. Meningococcal vaccine recommendations. CDC, Jul. 1, 2025.
20. https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html
21. https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html#table-age
22. https://www.vaccinesafety.edu/wp-content/up­loads/2025/01/Components-Excipients-24-1220-by-Vaccine-Type.pdf
23. https://www.chop.edu/vaccine-education-center/vac­cine-safety/vaccine-ingredients/ingredients-by-vaccine/meningococcal-vaccines-ingredients
24. Sodium chloride (injection route). Mayo Clinic, last updated Jul. 1, 2025.
25. Exley C, Clarkson E. Aluminium in human brain tis­sue from donors without neurodegenerative disease: a comparison with Alzheimer’s disease, multiple sclerosis and autism. Sci Rep. 2020 May 8;10(1):7770.
26. Children’s Health Defense Team. Read the fine print, part two—nearly 400 adverse reactions listed in vac­cine package inserts. Children’s Health Defense, Aug. 14, 2020.
27. Can meningococcal vaccine cause injury & death? National Vaccine Information Center, updated Dec. 6, 2024.
28. Meningococcal B vaccine. An immunogenic vaccine possibly useful during outbreaks. Prescrire Int. 2014 Sep;23(152):201-204.
29. England C. Minimum of 40 children paralyzed after new meningitis vaccine. La Leva di Archimede, Jan. 6, 2013. http://laleva.org/eng/2013/01/minimum_of_40_children_paralyzed_after_new_meningitis_vaccine.html
30. Viviani S. Efficacy and effectiveness of the meningococ­cal conjugate group A vaccine MenAfriVac® in pre­venting recurrent meningitis epidemics in sub-Saharan Africa. Vaccines (Basel). 2022 Apr 14;10(4):617.
31. https://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&FOLLOWOPTIONS=LATEST&VAX[]=6VAX-F&VAX[]=DTAPH&VAX[]=DTAPIPVHIB&VAX[]=DTPHIB&VAX[]=DTPIHI&VAX[]=DTPPHIB&VAX[]=DTPPVHBHPB&VAX[]=HBHEPB&VAX[]=HBPV&VAX[]=HIBV&VAX[]=MENHIB&VAX[]=MNQHIB&VAX[]=MEN&VAX[]=MENB&VAX[]=MNC&VAX[]=MNQ&VAX[]=MNP&VAX[]=PNC&VAX[]=PNC10&VAX[]=PNC13&VAX[]=PNC15&VAX[]=PNC20&VAX[]=PPV&VAX[]=PNC21&VAXTYPES[]=Haemophilus&VAXTYPES[]=Meningitis&VAXTYPES[]=Pneumonia
32. Lazarus R, Klompas M, Bernstein S. Electronic Support for Public Health–Vaccine Ad­verse Event Reporting System (ESP:VAERS). Grant Final Report, Agency for Healthcare Research and Quality (AHRQ), 2010.
33. Meningococcal vaccine side effects quite serious, linked to neurological disorders. Weltchek, Mallahan & Weltchek, n.d.
34. Christensen J. US children aer much more likely to die than kids in similar countries, study finds. CNN, Jul. 7, 2025.
35. Forrest CB, Koenigsberg LJ, Harvey FE, et al. Trends in US children’s mortality, chronic conditions, obesity, functional status, and symptoms. JAMA. 2025 Aug 12;334(6):509- 516.
36. Goodman B. Hundred of thousands of children have type 1 diabetes. Now, there’s a Barbie who has it, too. CNN, Jul. 8, 2025 (updated Jul. 10, 2025).
37. Sun LH. Meningitis B is rare but deadly. Parents who lost children to the disease wonder why no one mentioned a vaccine. The Washington Post, Jul. 22, 2019.
38. https://meningitisawareness.org
39. Halpern L. FDA grants full approval to mRNA-1273 COVID-19 vaccine in children at increased risk. Pharmacy Times, Jul. 10, 2025.
40. Burdick S. Public support for religious exemptions nearly doubled over past 6 years. The Defender, Feb. 3, 2025.
41. Hackell JM, Brothers K, Bode S, et al. Medical vs nonmedical immunization exemp­tions for child care and school attendance: policy statement. Pediatrics. 2025 Aug 1;156(2):e2025072714.
42. Meningococcal disease (Neisseria meningitidis) 2015 case definition. CDC, last reviewed Apr. 16, 2021. https://ndc.services.cdc.gov/case-definitions/meningococcal-disease-2015/
43. Teller M. Medical tests: whose interests do they really serve? Wise Traditions. Spring 2023;24(1):44-51.
44. O’Toole Z, Holland M (Eds.). Turtles All the Way Down: Vaccine Science and Myth. Children’s Health Defense, 2022, pp. 203-206.
45. Kennedy RF Jr, Hooker B. Vax-Unvax: Let the Science Speak. Skyhorse Publishing, 2023.
46. Exley C. Aluminium-based adjuvants should not be used as placebos in clinical trials. Vaccine. 2011;29(50):9289.
47. Goldman GS. Comparison of VAERS fetal-loss reports during three consecutive influenza seasons: was there a synergistic fetal toxicity associated with the two-vaccine 2009/2010 season? Hum Exp Toxicol. 2013;32(5):464-475.
48. Alexandrov PN, Pogue AI, Lukiw WJ. Synergism in aluminum and mercury neurotoxic­ity. Integr Food Nutr Metab. 2018;5(3):10.
49. Moskowitz R. Vaccines: A Reappraisal. Skyhorse Publishing, 2017.
50. Oliver SE, Moro P, Blain AE. Chapter 8: Haemophilus influenzae. CDC, May 21, 2024.
51. Haemophilus influenzae type b (Hib) – disease information statement (DIS). Physicians for Informed Consent, Aug. 2024. https://physiciansforinformedconsent.org/hib-dis/
52. Silfverdal SA, Bodin L, Hugosson S, et al. Protective effect of breastfeeding on invasive Haemophilus influenzae infection: a case-control study in Swedish preschool children. Int J Epidemiol. 1997 Apr;26(2):443-450.
53. Hib disease and vaccine quick facts. National Vaccine Information Center, updated Aug. 2, 2025.
54. https://www.merck.com/product/usa/pi_circulars/p/pedvax_hib/pedvax_pi.pdf
55. Aluminum in vaccines: what you need to know. Physicans for Informed Consent, Aug. 2020 (updated Dec. 2024). https://physiciansforinformedconsent.org/aluminum-in-vaccines/
56. Haemophilus influenzae type B (Hib) – vaccine risk statement (VRS). Physicians for Informed Consent, Aug. 2024. https://physiciansforinformedconsent.org/hib-vrs/
57. Institute of Medicine (US) Vaccine Safety Committee. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Stratton KR, Howe CJ, Johnston RB Jr (Eds.). Washington, DC: National Academies Press, 1994.
58. Children’s Health Defense Team. CDC, FDA prepare mass distribution of a Merck/Sanofi six-in-one vaccine for kids, turning blind eye to safety signals. The Defender, Jun. 25, 2021.
59. Children’s Health Defense Team. Infant deaths following vaccination: the numbers don’t lie—or do they? Children’s Health Defense, Sep. 17, 2018.
60. Can Hib vaccine cause injury & death? National Vaccine Information Center, updated Aug. 2, 2025.

This article appeared in Wise Traditions in Food, Farming and the Healing Arts, the quarterly journal of the Weston A. Price Foundation, Fall 2025

🖨️ Print post